Senior Finance Manager, J&J Innovative Medicine US Strategic Pricing

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:
Finance

Job Sub Function:
Finance Business Partners

Job Category:
People Leader

All Job Posting Locations:
Horsham, Pennsylvania, United States of America, Titusville, New Jersey, United States of America

Job Description:

J&J Innovative Medicine Pharmaceuticals Inc., a member of Johnson & Johnson's Family of Companies, is recruiting for a Senior Finance Manager, J&J Innovative Medicine US Strategic Pricing based in Titusville, NJ.

About Innovative Medicine

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements.

Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

The Senior Finance Manager, J&J Innovative Medicine US Strategic Pricing will be the key primary contact for several critical cross-portfolio J&J Innovative Medicine Pricing activities.  These include but are not limited to the Inflation Reduction Act, Emerging Government Policies, List Price Action analysis, the J&J Innovative Medicine US Transparency Report, and Long-Range Financial Planning.  In addition, this role will have oversight for the Neuroscience, Pulmonary Hypertension, and Established Product Group pricing finance activities and supervise a Manger and a Senior Financial Analyst.

This role will have significant visibility and impact for the J&J Innovative Medicine US Commercial organization.

The selected candidate will cover consolidated analysis and activities for over $40B of Gross-to-Net investment across seven therapeutic areas in various stages of the product lifecycle.  Due to the high degree of strategic impact, this role will frequently present to the Company Group Chair, Chief Strategic Customer Officer, Regional CFO, and Business Unit Presidents.

Additionally, a key responsibility of this role will be leadership for the Inflation Reduction Act (IRA) for J&J Innovative Medicine US.  The Inflation Reduction Act (IRA) is a law that was passed in August 2022, and is the largest government policy change to the prescription drug market since the Medicare Modernization Act of 2003.

The IRA includes several provisions that are designed to lower prescription drug prices for Medicare beneficiaries, including rebate...